cleveland clinic l-carnitine study γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to TMAO: Cell Metabolism Potential New Class of Drugs

Potential New Class of Drugs Developed at Cleveland Clinic May Reduce Cardiovascular Risk by Targeting Gut Microbes Cleveland Clinic Researchers First to Show Dietary Choline and Gut Bacteria Byproduct Linked with Increased Blood Clotting Risk, Heart Disease New study links L carnitine in red meat to heart disease Harvard Health Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Cleveland Clinic Studies Reveal Role of Red Meat in Gut Bacteria, Heart Disease Development

SKU: 23507415100 · From metron-ms.com